Abstract
Although fungal infections are common in clinical practice, usually they are superficial and invasive infections are very rare among immunocompetent people. Invasive fungal infections in immunocompromised people are life threatening if left untreated. Among invasive fungal infections, mucormycosis is uncommon. Pulmonary mucormycosis is rarely seen in clinical practice and is often life-threatening. This case report describes a patient with poorly controlled diabetes who presented with pulmonary mucormycosis and responded well to systemic antifungals.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
